Edition:
India

Accelerate Diagnostics Inc (AXDX.OQ)

AXDX.OQ on NASDAQ Stock Exchange Capital Market

24.70USD
20 Apr 2018
Change (% chg)

$0.35 (+1.44%)
Prev Close
$24.35
Open
$24.25
Day's High
$24.70
Day's Low
$24.25
Volume
15,747
Avg. Vol
80,768
52-wk High
$30.45
52-wk Low
$16.85

Chart for

About

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic... (more)

Overall

Beta: 2.04
Market Cap(Mil.): $1,227.62
Shares Outstanding(Mil.): 55.30
Dividend: --
Yield (%): --

Financials

BRIEF-Accelerate Diagnostics announces pricing of $150 mln notes offering

* ACCELERATE DIAGNOSTICS, INC. ANNOUNCES PRICING OF $150 MILLION CONVERTIBLE NOTES OFFERING

23 Mar 2018

BRIEF-Accelerate Diagnostics Announces $150 Mln Convertible Notes Offering

* ACCELERATE DIAGNOSTICS INC. ANNOUNCES $150 MILLION CONVERTIBLE NOTES OFFERING

22 Mar 2018

BRIEF-Accelerate Diagnostics Qtrly Net Loss $0.27 Per Share

* ACCELERATE DIAGNOSTICS REPORTS Q4 AND FULL-YEAR FINANCIAL RESULTS FOR 2017

16 Feb 2018

BRIEF-Accelerate Diagnostics says ‍on Nov 14, board increased its size to 8 members​

* Accelerate Diagnostics says ‍on Nov 14, board increased size of board to 8 members​ - SEC Filing Source text: [http://bit.ly/2iocMIO] Further company coverage:

17 Nov 2017

BRIEF-Accelerate Diagnostics reports Q3 loss per share $0.31

* Accelerate Diagnostics Inc reports q3 2017 financial results

03 Nov 2017

Earnings vs. Estimates